Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anne-Elisabeth Petit"'
Autor:
Anne-Elisabeth Petit, Nathalie Demotte, Benoît Scheid, Claude Wildmann, René Bigirimana, Monica Gordon-Alonso, Javier Carrasco, Salvatore Valitutti, Danièle Godelaine, Pierre van der Bruggen
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-15 (2016)
Galectin-3 is a sugar-binding protein that can inhibit antitumour cytotoxic immunity. Here the authors show that Galectin-3 expressed by tumour cells inhibits LFA-1 on cytotoxic lymphocytes, impairing immunological synapse formation, IFNg secretion,
Externí odkaz:
https://doaj.org/article/3477da4108d44f4daa43367177312336
Autor:
Claire Christophe, Sabina Müller, Magda Rodrigues, Anne-Elisabeth Petit, Patrick Cattiaux, Loïc Dupré, Sébastien Gadat, Salvatore Valitutti
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0120053 (2015)
The dynamics of the interaction between Cytotoxic T Lymphocytes (CTL) and tumor cells has been addressed in depth, in particular using numerical simulations. However, stochastic mathematical models that take into account the competitive interaction b
Externí odkaz:
https://doaj.org/article/69236bb002ce492eb8acc067b6db9a43
Autor:
Nicolas Rodondi, Axel Lennart Löwe, Denis O'Mahony, Aðalsteinn Gudmundsson, Antonio Cherubini, Roy L. Soiza, Anne-Elisabeth Petit, Bastiaan T.G.M. Sallevelt, Olivia Dalleur, Clara Drenth, Anne Spinewine, Isabelle De Brauwer, Kieran Dalton, Silvan Thürig, Agapios Panos, Jamie J Coleman, Dimitris Mavridis, Pauline Anrys, Mirko Petrovic, Andrea Correa-Pérez, Stefanie Thevelin
Publikováno v:
Journal of the American Medical Directors Association
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
Journal of the American Medical Directors Association, Vol. 22, no. 10, p. 2121-2133.e24 (2021)
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
Journal of the American Medical Directors Association, Vol. 22, no. 10, p. 2121-2133.e24 (2021)
Objectives We aimed to establish an explicit list of potentially clinically significant drug-drug interactions (DDIs) in people aged ≥65 years. Design A preliminary list of potentially clinically significant DDIs was compiled, based on 154 DDIs ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78e3c1a6970f3a74ef8e87f260c5f52f
https://hdl.handle.net/10641/2570
https://hdl.handle.net/10641/2570
Autor:
Salvatore Valitutti, Anne-Elisabeth Petit, Mónica Gordón-Alonso, Benoit Scheid, René Bigirimana, Danièle Godelaine, Javier Carrasco, Pierre van der Bruggen, Claude Wildmann, Nathalie Demotte
Publikováno v:
Nature Communications, Vol. 7, p. 12242 [1-15] (2016)
Nature Communications
Nature communications, 7
Nature Communications, Vol 7, Iss 1, Pp 1-15 (2016)
Nature communications, 7 (12242
Nature Communications
Nature communications, 7
Nature Communications, Vol 7, Iss 1, Pp 1-15 (2016)
Nature communications, 7 (12242
Surface galectin has been shown to contribute to dysfunctions of human tumour-infiltrating lymphocytes (TILs). We show here that galectin-covered CD8 TILs produce normal amounts of intracellular cytokines, but fail to secrete them because of defectiv
Autor:
Magda Rodrigues, Florie Bertrand, Jérôme Delon, Anne-Elisabeth Petit, Sophie Duchez, Salvatore Valitutti, Michael Esquerre
Publikováno v:
The Journal of Immunology. 185:2887-2894
A key feature in T lymphocyte biology is that Th cells rapidly polarize their secretory machinery toward cognate APCs. The molecular mechanisms of these dynamic Th cell responses and their impact on APC biology remain to be elucidated. In this study,
Autor:
Claire Christophe, Sabina Müller, Magda Rodrigues, Anne-Elisabeth Petit, Patrick Cattiaux, Loïc Dupré, Sébastien Gadat, Salvatore Valitutti
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 3, p e0120053 (2015)
PLoS ONE, Vol 10, Iss 3, p e0120053 (2015)
The dynamics of the interaction between Cytotoxic T Lymphocytes (CTL) and tumor cells has been addressed in depth, in particular using numerical simulations. However, stochastic mathematical models that take into account the competitive interaction b